Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Degenerative Neurological and Neuromuscular Disease|February 9, 2023
Neuroimaging Correlates of Patient-Reported Outcomes in Multiple SclerosisDejan Jakimovski, Taylor R Wicks, Niels Bergsland, et al.
Degenerative Neurological and Neuromuscular Disease|August 1, 2022
Istradefylline for OFF Episodes in Parkinson's Disease: A US Perspective of Common Clinical ScenariosStuart H Isaacson, Sagari Betté, Rajesh Pahwa
Degenerative Neurological and Neuromuscular Disease|December 20, 2023
Development and Validation of a Risk Prediction Model to Estimate the Risk of Stroke Among Hypertensive Patients in University of Gondar Comprehensive Specialized Hospital, Gondar, 2012 to 2022Yazachew Moges Chekol, Mehari Woldemariam Merid, Getayeneh Antehunegn Tesema, et al.
Degenerative Neurological and Neuromuscular Disease|September 25, 2023
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking PointsErin Faraclas
Degenerative Neurological and Neuromuscular Disease|February 25, 2026
Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related DisordersXingyu Xia, Xi Chen, Yiming Sun, et al.
Degenerative Neurological and Neuromuscular Disease|June 18, 2026
Marked Clinical Improvement in Parkinson's Disease Following Double-Filtration Apheresis: A Case ReportHarald Burgard
Degenerative Neurological and Neuromuscular Disease|August 21, 2023
Risk of Obstructive Sleep Apnea in Saudi Male Boys with Duchenne Muscular Dystrophy (DMD)Ahmed Bamaga, Lama Alqarni
Degenerative Neurological and Neuromuscular Disease|November 6, 2019
Orphan Drugs In Development For The Treatment Of Friedreich's Ataxia: Focus On OmaveloxoloneShaila D Ghanekar, Wai Wai Miller, Colin J Meyer, et al.
Degenerative Neurological and Neuromuscular Disease|February 6, 2020
Prostaglandins as the Agents That Modulate the Course of Brain DisordersHamidreza Famitafreshi, Morteza Karimian
Degenerative Neurological and Neuromuscular Disease|December 1, 2018
Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-IIAlper Dai, Osman Baspinar, Ahmet Yeşilyurt, et al.
Pageof 15